Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
7/4/24 Roche (ROG) Tiragolumab for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
7/2/24 Annovis Bio (ANVS) Buntanetap for Parkinson's Disease (PD) Subscribers Only Subscribers Only Subscribers Only
6/27/24 Immutep Ltd. (IMMP) Eftilagimod Alpha for Head and Neck Cancer Subscribers Only Subscribers Only Subscribers Only
6/27/24 CalciMedica (CALC) Auxora for Pancreatitis Subscribers Only Subscribers Only Subscribers Only
6/26/24 Merck (MRK) Patritumab Deruxtecan for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
07/13/24 Subscribers Only Subscribers Only Trial Data - Updated Results
Now - 07/14/24 Subscribers Only Subscribers Only Trial Data - Updated Results
Now - 07/15/24 Subscribers Only Subscribers Only Trial Announcement - Initiation
Now - 07/15/24 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)
Now - 07/15/24 Subscribers Only Subscribers Only Regulatory - Approval Decision (Europe)